ÂÜÀòÂÒÂ×

Nils Köhler is an accomplished professional in analytical development and quality control, currently serving as the Analytical Development and Quality Control Leader at Santhera Pharmaceuticals since March 2024. Prior roles include Associate Director of Analytical Development and Quality Control Drug Substance at Idorsia Pharmaceuticals Ltd from July 2019 to November 2023, where responsibilities encompassed management of analytical activities compliant with cGMP standards, method validation, risk assessments, and training lab technicians. Nils also held positions at Novartis, CSL Behring, Basilea Pharmaceutica, and Sanofi-Aventis, accumulating extensive experience in laboratory leadership, analytical project oversight, method development, and troubleshooting. Academic credentials include a Post Doc in Natural Product Chemistry and a Doctorate in Food Chemistry/Natural Products Chemistry from Technische Universität Braunschweig.